Simplified Chinese
Public Consultation on the First Phase of the Minhai Biotechnology International Vaccine Industrial Base Project
Release date:
2019-02-20
Author:
Source:
Abstract
In accordance with the Environmental Impact Assessment Law of the People’s Republic of China and the relevant provisions of Ministry Order No. 4, “Measures for Public Participation in Environmental Impact Assessment,” the following information regarding the environmental impact assessment of the construction project is hereby made public:
(1) The full-text Baidu Netdisk link to the draft Environmental Impact Report is:
Link: https://pan.baidu.com/s/1FJZbW9dheUlA-29VbAcDQQ
Extraction code: azip
Paper copies of the report shall be made available for public inspection at the locations of both the project proponent and the environmental impact assessment agency.
(2) Scope of the public consulted:
The public within a 2.5 km rectangular area surrounding the project site.
(3) Online link to the public opinion form:
http://www.biominhai.com/xwzx_xi/newsId=347.html
(4) The methods and channels through which the public may submit their comments;
① You may complete the public opinion form as an electronic spreadsheet, And send it by email to xiazhanxiong@biominhai.com. ;
② A public comment form is available for printing and may be mailed to the address of the project proponent: No. 35 Simiao Road, Daxing Biomedical Industry Base, Zhongguancun Science Park, Daxing District, Beijing, Postal Code 102629.
③ Fax number: 010-59613636
(5) The start and end dates for public comments.
February 25, 2019 – March 11, 2019
Construction Entity: Beijing Minhai Biotechnology Co., Ltd.
(6) Name of the Project Owner: Beijing Minhai Biotechnology Co., Ltd.
Contact: Engineer Xia
Contact number: 010-59613634
Email: xiazhanxiong@biominhai.com
Beijing Minhai Biotechnology Co., Ltd.
February 25, 2019
Keywords:
Recommended Reading
Batch Release Status of the Company’s Products in 2026
2026-07-23
2026-07-15
2026-07-09